SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) testing: Joseph Yao, M.D.

Joseph Yao, M.D., explains how Mayo Clinic Laboratories' four-target test for viral respiratory disease provides vital information for the treatment of at-risk patients. The PCR test detects RNA from SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus, or RSV. A standalone PCR test for RSV is also available.

Show Notes

(00:43):

Before we get started, Dr. Yao, could you please provide our listeners with a little bit about you and your background?
 
(01:24)
 Can you provide a brief overview and intended use of this testing? 

(02:34)
 Could you describe which patients should have this testing and when should it be performed? 

(05:07)
 Are there other options on the market? And if so, what makes our testing unique?

(06:38)
 How are the test results used in patient care?

What is Answers from the Lab?

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.